Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 225,110 | 272,260 | 250,991 | 27,685 | 0 |
| Cost of Goods | 39,374 | 36,815 | 34,621 | 5,572 | N/A |
| Gross Profit | 185,736 | 235,445 | 216,370 | 22,113 | N/A |
| Operating Expenses | 216,512 | 275,305 | 311,646 | 315,075 | 276,596 |
| Operating Income | -30,402 | -39,045 | -94,655 | -292,390 | -276,596 |
| Interest Expense | 14,046 | 15,019 | 10,985 | 720 | 0 |
| Other Income | -15,340 | -21,478 | -7,918 | 1,155 | 585 |
| Pre-tax Income | -59,788 | -75,542 | -113,558 | -291,955 | -276,011 |
| Income Tax | 207 | 53 | 17 | N/A | N/A |
| Net Income Continuous | -59,995 | -75,595 | -113,575 | -291,955 | -276,011 |
| Net Income | $-59,995 | $-75,595 | $-113,575 | $-291,955 | $-276,011 |
| EPS Basic Total Ops | -1.52 | -1.95 | -2.99 | -7.85 | -8.29 |
| EPS Basic Continuous Ops | -1.52 | -1.95 | -2.99 | -7.85 | -8.29 |
| EPS Diluted Total Ops | -1.52 | -1.95 | -2.99 | -7.85 | -8.29 |
| EPS Diluted Continuous Ops | -1.52 | -1.95 | -2.99 | -7.85 | -8.29 |
| EPS Diluted Before Non-Recurring Items | -1.52 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-20,369 | $-30,968 | $-87,271 | $-289,579 | $-275,447 |